Medicare costs and health resource utilisation associated with atrial fibrillation in the elderly

Journal of Medical Economics

Volumn 8, Issue 55-65, 2005, Pages 55-65

  Pelletier, Elise M ^a   Hernandez, John ^a   Clark, Mary Ann ^a   Lahue, Betsy Justason ^a   Reyes, Carolina M ^a   Morady, Fred ^b  

^a BOSTON SCIENTIFIC CORPORATION   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Atrial fibrillation; Cost benefit analysis; Medicare; Resource use

Indexed keywords

AGED; ARTICLE; COMORBIDITY; CONSULTATION; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; FEMALE; FOLLOW UP; GERIATRIC CARE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH SERVICE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOMES RESEARCH;

EID: 17444399025     PISSN: 1369698X     EISSN: None     Source Type: Journal    
DOI: 10.3111/200508055065     Document Type: Article

References (41)

1. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA: Journal of the American Medical Association 2001; 285: 2370-2375.
2. Dell'Orfano JT, Kramer RK, Naccarelli GV. Cost-effective strategies in the acute management of atrial fibrillation. Current Opinion in Cardiology 2000; 15: 23-28.
3. Furberg CD, Psaty BM, Manolio TA et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). American Journal of Cardiology 1994; 74: 236-241.
4. Kannel WB, Wolf PA, Benjamin EJ et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. American Journal of Cardiology 1998; 82(8A): 2N-9N.
5. Wolf PA, Benjamin EJ, Belanger AJ et al. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. American Heart Journal 1996; 131: 790-795.
6. Hart RG. Atrial fibrillation and stroke prevention [comment]. New England Journal of Medicine 2003; 349: 1015-1016.
7. Lin HJ, Wolf PA, Kelly-Hayes M et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996; 27: 1760-1764.
8. Jorgensen HS, Nakayama H, Reith J et al. Stroke recurrence: predictors, severity, and prognosis. The Copenhagen Stroke Study. Neurology 1997; 48: 891-895.
9. Dorian P, Jung W, Newman D et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. Journal of the American College of Cardiology 2000; 36: 1303-1309.
10. Hamer ME, Blumenthal JA, McCarthy EA et al. Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia. American Journal of Cardiology 1994; 74: 826-829.
11. Lip GY, Tean KN, Dunn FG. Treatment of atrial fibrillation in a district general hospital. British Heart Journal 1994; 71: 92-95.
12. Carlsson J, Neuzner J, Rosenberg YD. Therapy of atrial fibrillation: rhythm control versus rate control. Pacing and Clinical Electrophysiology: PACE 2000; 23: 891-903.
13. Stafford RS, Robson DC, Misra B et al. Rate control and sinus rhythm maintenance in atrial fibrillation: national trends in medication use, 1980-1996. Archives of Internal Medicine 1998; 158: 2144-2148.
14. Lumer GB, Roy D, Talajic M et al. Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial. European Heart Journal 2002; 23: 1050-1056.
15. Botkin SB, Dhanekula LS, Olshansky B. Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs. American Heart Journal 2003; 145: 233-238.
16. Weerasooriya R, Jais P, Le Heuzey JY et al. Cost analysis of catheter ablation for paroxysmal atrial fibrillation. Pacing and Clinical Electrophysiology: PACE 2003; 26 (1 Pt 2): 292-294.
17. Hravnak M, Hoffman LA, Saul MI et al. Resource utilization related to atrial fibrillation after coronary artery bypass grafting. American Journal of Critical Care 2002; 11: 228-238.
18. Kim MH, Rachwal W, McHale C et al. Effect of amiodarone +/- diltiazem +/-beta blocker on frequency of atrial fibrillation, length of hospitalization, and hospital costs after coronary artery bypass grafting. American Journal of Cardiology 2002; 89: 1126-1128.
19. Reddy P, Dunn AB, White CM et al. An economic analysis of amiodarone versus placebo for the prevention of atrial fibrillation after open heart surgery. Pharmacotherapy 2002; 22: 75-80.
20. Clark MA, Bakhai A, Lacey MJ et al. Clinical and economic outcomes of percutaneous coronary interventions in the elderly: an analysis of Medicare claims data. Circulation 2004; 110: 259-264.
21. Harrington C, Zagari MJ, Corea J et al. A cost analysis of diabetic lower-extremity ulcers. Diabetes Care 2000; 23: 1333-1338.
22. Delea TE, Vera-Llonch M, Edelsberg JS et al. The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer. Value in Health 2002; 5: 35-43.
23. Albert SM, Glied S, Andrews H et al. Primary care expenditures before the onset of Alzheimer's disease. Neurology 2002; 59: 573-578.
24. CMS. Personal health care expenditures aggregate and per capita amounts and percent distribution, by source of funds: selected calendar years 1980-2002. National Health Accounts, 2004.
25. Wu EQ, Birnbaum HG, Mareva MN. Healthcare cost and comorbidities associated with atrial fibrillation. International Society for Pharmacoeconomics and Outcomes Research 9th Annual International Meeting, Arlington, VA, 16-19 May 2004 (abstract).
26. Le Heuzey JY, Paziaud O, Piot O et al. Cost of care distribution in atrial fibrillation patients: the COCAF study. American Heart Journal 2004; 147: 121-126.
27. Stewart S, Murphy N, Walker A et al. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 2004; 90: 286-292.
28. Baine WB, Yu W, Weis KA. Trends and outcomes in the hospitalization of older Americans for cardiac conduction disorders or arrhythmias, 1991-1998. Journal of the American Geriatrics Society 2001; 49: 763-770.
29. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 2003; 108: 711-716.
30. Wolf PA, Mitchell JB, Baker CS et al. Impact of atrial fibrillation on mortality, stroke, and medical costs. Archives of Internal Medicine 1998; 158: 229-234.
31. Nichol G, McAlister F, Pham B et al. Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart 2002; 87: 535-543.
32. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000; 356: 1789-1794.
33. Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. New England Journal of Medicine 2002; 347: 1825-1833.
34. McAnulty JH. Barriers to the use of warfarin: potential solutions. Journal of Interventional Cardiac Electrophysiology 2004; 10 (Suppl 1): 17-20.
35. Cox JL, Schuessler RB, D'Agostino HJ et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. Journal of Thoracic and Cardiovascular Surgery 1991; 101: 569-583.
36. Raman JS, Ishikawa S, Power JM. Epicardial radiofrequency ablation of both atria in the treatment of atrial fibrillation: experience in patients. Annals of Thoracic Surgery 2002; 74: 1506-1509.
37. Raman J, Ishikawa S, Storer MM et al. Surgical radiofrequency ablation of both atria for atrial fibrillation: results of a multicenter trial. Journal of Thoracic and Cardiovascular Surgery 2003; 126: 1357-1366.
38. Kottkamp H, Hindricks G, Autschbach R et al. Specific linear left atrial lesions in atrial fibrillation: intraoperative radiofrequency ablation using minimally invasive surgical techniques. Journal of the American College of Cardiology 2002; 40: 475-480.
39. Gillinov AM, McCarthy PM. Curative surgery for atrial fibrillation: current status and minimally invasive approaches. Expert Review of Cardiovascular Therapy 2003; 1: 595-603.
40. Pappone C, Rosanio S, Augello G et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. Journal of the American College of Cardiology 2003; 42: 185-197.
41. Oral H, Scharf C, Chugh A et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003; 108: 2355-2360.